Fundraising Fox
/Companies
Sign in

Revisto

20 employees on LinkedIn · 3 known investors

Find your way into Revisto

Sign up to see every warm intro you have to Revisto

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Revisto team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Revisto offers an AI-driven platform that automates compliance review and approval of promotional and marketing materials for pharmaceutical companies, learning from regulations, industry best practices, and customer history. It aims to reduce review cycle time and support the creation of compliant, personalized content, and counts a Top 5 pharmaceutical company among its customers.

AI & Machine LearningHealthtechMarketing TechMedical Devices

Investors · 3

Tau Ventureslisted by Tau VenturesPalo Alto · $500K

How we know: Tau Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

LiveOak VenturesreportedAustin · $500K – $10M

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$4M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

Novisto Montreal, CanadaNovisto offers an enterprise sustainability management platform for ESG, carbon, risk, and performance data, covering planning, data management, reporting, analysis, and regulatory disclosures such as CSRD. It includes embedded AI capabilities for sustainability teams handling data validation, document analysis, and reporting.

Companies working in the same space as Revisto.

Frequently asked questions

What does Revisto do?
Revisto offers an AI-driven platform that automates compliance review and approval of promotional and marketing materials for pharmaceutical companies, learning from regulations, industry best practices, and customer history. It aims to reduce review cycle time and support the creation of compliant, personalized content, and counts a Top 5 pharmaceutical company among its customers.
Who are Revisto's investors?
Revisto's investors include Alloy Partners, Tau Ventures, LiveOak Ventures.
How much funding has Revisto raised?
Revisto has disclosed $4M raised across 1 round.